Nebius Group N.V. (NBIS) vs Novo Nordisk A/S (NVO)
A side-by-side comparison of Nebius Group N.V. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: NBIS is classified in Technology; NVO is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
NBIS
Nebius Group N.V.
$169.69TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT
NVO
Novo Nordisk A/S
$50.96HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — NBIS vs NVO
growth of $100 · dividends reinvested · last 2yNBIS +839.4%NVO -55.3%NBIS compounded faster
Log scale — wide-divergence pair
NBIS NVO
NBIS vs NVO: by the numbers
- •NVO is the larger company ($226.46B vs $40.73B market cap).
- •NVO trades at the lower trailing earnings multiple (11.62 vs 62.63 P/E), one valuation lens rather than an overall verdict.
- •NBIS converts more revenue to profit (95.27% vs 37.14% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs -23.11% CAGR).
- •NVO pays a dividend (3.63% yield), while NBIS has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | NBIS | NVO |
|---|---|---|
| P/E ratio | 62.63 | 11.62 |
| P/S ratio | 66.12 | 4.31 |
| P/B ratio | 8.02 | 7.06 |
| PEG ratio | N/A | 8.16 |
| EV / EBITDA | N/A | 9.05 |
| FCF yield | N/A | 2.19% |
Profitability
| Metric | NBIS | NVO |
|---|---|---|
| Gross margin | 68.63% | 81.83% |
| Operating margin | -112.53% | 45.21% |
| Net margin | 95.27% | 37.14% |
| ROE | 11.55% | 60.74% |
| ROIC | -4.75% | 29.53% |
Dividends
| Metric | NBIS | NVO |
|---|---|---|
| Dividend yield | N/A | 3.63% |
| Payout ratio | N/A | 49.80% |
Growth (annualized)
| Metric | NBIS | NVO |
|---|---|---|
| Revenue CAGR (5Y) | -23.11% | 20.73% |
| EPS CAGR (5Y) | -35.43% | 19.59% |
| FCF CAGR (5Y) | N/A | -5.86% |
| Total return CAGR (5Y) | N/A | 4.23% |
Frequently asked
- Which has the lower trailing P/E, NBIS or NVO?
- NVO has the lower trailing P/E: NBIS trades at 62.63 and NVO at 11.62. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, NBIS or NVO?
- Over the past five years, NVO grew revenue faster — NBIS at a -23.11% CAGR versus NVO at 20.73%.
- Does NBIS or NVO pay a bigger dividend?
- NVO pays a dividend (3.63% yield), while NBIS has no payments in the available dividend history.
- Is NBIS or NVO more profitable?
- NBIS runs the higher net margin — NBIS at 95.27% versus NVO at 37.14%.
Go deeper
Dig into the metrics
Nebius P/E ratioNovo Nordisk A/S P/E ratioNebius dividend yieldNovo Nordisk A/S dividend yieldNebius ROENovo Nordisk A/S ROENebius operating marginNovo Nordisk A/S operating marginNebius revenue growthNovo Nordisk A/S revenue growthNebius free cash flowNovo Nordisk A/S free cash flow
Nebius & Novo Nordisk A/S appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.